title: Reply to Daskapan et al.
authors: National Institute for Research in Tuberculosis, Chennai, India.
authors: Gopalan
authors: G
authors: Narendran
authors: National Institute for Research in Tuberculosis, Chennai, India.
authors: Soumya
authors: S
authors: Swaminathan
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D012293:Rifampin / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D012293:Rifampin